Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 23 studies | 44% ± 16% | |
classical monocyte | 22 studies | 33% ± 14% | |
monocyte | 17 studies | 29% ± 11% | |
conventional dendritic cell | 14 studies | 29% ± 17% | |
dendritic cell | 11 studies | 27% ± 15% | |
oligodendrocyte | 11 studies | 25% ± 9% | |
macrophage | 10 studies | 24% ± 7% | |
mast cell | 10 studies | 27% ± 12% | |
neutrophil | 7 studies | 23% ± 5% | |
myeloid cell | 7 studies | 29% ± 9% | |
mononuclear phagocyte | 5 studies | 24% ± 7% | |
endothelial cell | 5 studies | 22% ± 4% | |
hematopoietic precursor cell | 4 studies | 21% ± 0% | |
epithelial cell | 4 studies | 27% ± 7% | |
GABAergic neuron | 3 studies | 27% ± 8% | |
glutamatergic neuron | 3 studies | 36% ± 8% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 40% ± 15% | |
alveolar macrophage | 3 studies | 25% ± 6% | |
basal cell | 3 studies | 18% ± 2% | |
microglial cell | 3 studies | 23% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 2327.83 | 89 / 89 | 100% | 30.48 | 897 / 901 |
liver | 100% | 1996.64 | 226 / 226 | 100% | 32.38 | 404 / 406 |
thymus | 99% | 1168.21 | 649 / 653 | 99% | 13.06 | 597 / 605 |
skin | 99% | 1932.67 | 1790 / 1809 | 99% | 28.87 | 466 / 472 |
adrenal gland | 100% | 1577.21 | 258 / 258 | 97% | 17.67 | 222 / 230 |
stomach | 98% | 1018.76 | 353 / 359 | 98% | 17.02 | 280 / 286 |
breast | 100% | 1355.22 | 459 / 459 | 96% | 19.90 | 1074 / 1118 |
intestine | 100% | 1621.22 | 966 / 966 | 96% | 15.82 | 505 / 527 |
lung | 99% | 1551.41 | 575 / 578 | 95% | 13.99 | 1102 / 1155 |
prostate | 98% | 1297.89 | 241 / 245 | 96% | 13.15 | 483 / 502 |
ovary | 94% | 837.27 | 169 / 180 | 98% | 13.99 | 422 / 430 |
esophagus | 100% | 1910.22 | 1441 / 1445 | 89% | 11.55 | 162 / 183 |
bladder | 100% | 1294.10 | 21 / 21 | 79% | 12.58 | 400 / 504 |
uterus | 98% | 1008.58 | 166 / 170 | 75% | 11.53 | 345 / 459 |
brain | 88% | 1001.94 | 2321 / 2642 | 73% | 7.41 | 515 / 705 |
pancreas | 36% | 178.97 | 119 / 328 | 93% | 12.35 | 166 / 178 |
adipose | 100% | 1564.36 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 23.66 | 80 / 80 |
spleen | 100% | 3413.67 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.51 | 1 / 1 |
blood vessel | 99% | 2022.57 | 1328 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 19.76 | 44 / 45 |
peripheral blood | 96% | 11920.53 | 895 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 16.13 | 26 / 29 |
heart | 89% | 789.93 | 764 / 861 | 0% | 0 | 0 / 0 |
muscle | 84% | 598.55 | 676 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0017018 | Molecular function | myosin phosphatase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | CPPED1 |
Protein name | Serine/threonine-protein phosphatase CPPED1 (EC 3.1.3.16) (Calcineurin-like phosphoesterase domain-containing protein 1) (Complete S-transactivated protein 1) |
Synonyms | CSTP1 |
Description | FUNCTION: Protein phosphatase that dephosphorylates AKT family kinase specifically at 'Ser-473', blocking cell cycle progression and promoting cell apoptosis. May play an inhibitory role in glucose uptake by adipocytes. . |
Accessions | ENST00000261660.4 [Q9BRF8-3] ENST00000381774.9 [Q9BRF8-1] Q9BRF8 ENST00000433677.6 [Q9BRF8-2] |